von Willebrand Factor Antibodies – vWF
Affinity Biologicals, Inc. manufactures a broad range of von Willebrand Factor Antibodies – vWF which can be found in the listing below. Further information about each individual von Willebrand Factor Antibodies – vWF is available by following the associated links. Our von Willebrand Factor Antibodies – vWF are excellent for use in immunoassays where high sensitivity is required and are frequently the preferred reagent for immunopreciptaion techniques and activity neutralization assays. These antibodies have proven to be extremely useful in the preparation of immune-adsorbent resins for use in immuno-depletion of specific proteins from plasma as well as immuno-affinity purification of proteins. Affinity’s von Willebrand Factor Antibodies – vWF are manufactured for use in research applications.
|vWF, Human||Host||Catalogue No.||Size|
|Purified IgG||Goat||GAVWF-IG||2.5mg vial|
|Affinity Purified, IgG||Goat||GAVWF-AP||0.5mg vial|
|Peroxidase Conjugated IgG||Goat||GAVWF-HRP||0.15mg vial|
|Affinity Purified, FITC conjugated IgG||Goat||GAVWF-APFTC||0.1mg vial|
|Affinity Purified, Biotinylated IgG||Goat||GAVWF-APBIO||0.1mg vial|
|Matched Pair Antibodies for EIA||VWF-EIA||5 plates|
|vWF, Canine||Host||Catalogue No.||Size|
|Purified IgG||Sheep||SACWF-IG||5mg vial|
|Peroxidase Conjugated IgG||Sheep||SACWF-HRP||0.2mg vial|
|vWF, Rat||Host||Catalogue No.||Size|
|Purified IgG||Sheep||SARTW-IG||5mg vial|
|Peroxidase Conjugated IgG||Sheep||SARTW-IG||0.2mg vial|
Listing of von Willebrand Factor Antibodies – vWF
GAVWF-IG – Goat anti human vWF – von Willebrand Factor, purified IgG (2.5mg vial)
SACWF-IG – Sheep anti Canine vWF – von Willebrand Factor, purified IgG (5mg vial)
SARTW-IG – Sheep anti rat vWF – von Willebrand Factor, purified IgG (5mg vial)
SACWF-HRP – Sheep anti Canine vWF – von Willebrand Factor, peroxidase conjugated IgG (0.2 mg vial)
GAVWF-APFTC – Goat anti human vWF – von Willebrand Factor, affinity purified, FITC conjugated IgG (0.1 mg vial)
GAVWF-APBIO – Goat anti human vWF – von Willebrand Factor, affinity purified, Biotinylated IgG (0.1 mg vial)
SARTW-HRP – Sheep anti Rat vWF – von Willebrand Factor, peroxidase conjugated IgG (0.2 mg vial)
GAVWF-HRP – Goat anti human vWF – von Willebrand Factor, peroxidase conjugated IgG (0.15 mg vial)
GAVWF-AP – Goat anti human vWF – von Willebrand Factor, affinity purified IgG (0.5 mg vial)
VWF-EIA – von Willebrand Factor Paired Antibody Set – 5 plate set
Description of von Willebrand Factor -vWF
von Willebrand Factor (vWF, also previously referred to as Factor VIII related antigen) is a large adhesive protein produced in endothelial cells and megakaryocytes. There are two critical functions of vWF, the first being its involvement in the process of platelet adhesion and aggregation through interaction with platelet receptor glycoprotein Ib, the second being the binding and stabilization of Factor VIII (antihemophilic factor) for secretion and transport in plasma. The vWF precursor protein is synthesized with a 95,000 dalton propeptide (also known as vWF antigen-II), believed to be involved in the intracellular multimerization of the vWF subunits. The mature vWF multimers are then packed into storage organelles within the cell (Weibel-Palade bodies) after which the propeptide is cleaved and released. vWF circulates as multimers of disulphide linked 220,000 dalton subunits and the molecular weight of these multimers ranges from 0.5-20 million daltons.
The plasma concentration of vWF is typically 10 μg/ml, but increased levels are often observed in pregnancy and other conditions of physiological stress. von Willebrand’s disease (vWD) is perhaps the most common inherited bleeding disorder in humans and is the result of either quantitative deficiencies of vWF (vWD Types I & III), or one of a number of qualitative disorders of vWF structure and function (vWD Type II).
References and Reviews
- Montgomery RR, Coller BS, in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 134-168, J.B. Lippincott Co., Philadelphia PA,.USA, 1994.
- Sadler JE; von Willebrand Factor (Minireview); JBC 266:34, pp 22777-22780, 1991.